Mark Ayers
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers 22
- Colorectal Cancer Treatments and Studies 10
- HER2/EGFR in Cancer Research 6
- Pancreatic and Hepatic Oncology Research 5
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 18
- Breast Cancer Treatment Studies 8
- Immunology top 1%
-
- Lung Cancer Treatments and Mutations 9
-
- Gene expression and cancer classification 9
- Co-authors
- Lajos PusztaiJames StecJared LuncefordW. Fraser SymmansJeffrey S. RossGabriel N. HortobágyiAndrey LobodaSarina A. Piha‐Paul
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (8 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Mark Ayers
55 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 5.2k
- Cancer Research 2.7k
- Immunology 1.6k
- Pulmonary and Respiratory Medicine 1.9k
- Pathology and Forensic Medicine 780
Countries citing papers authored by Mark Ayers
This map shows the geographic impact of Mark Ayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Ayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Ayers more than expected).
Fields of papers citing papers by Mark Ayers
This network shows the impact of papers produced by Mark Ayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Ayers. The network helps show where Mark Ayers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Ayers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 40 | |
| 3 | 2022 | 54 | |
| 4 | 2021 | 40 | |
| 5 | 2018 | 27 | |
| 6 | T-Cell–Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028breakdown → | 2018 | 656 |
| 7 | 2017 | 5 | |
| 8 | 2016 | 52 | |
| 9 | 2015 | 73 | |
| 10 | 2015 | 5 | |
| 11 | 2013 | 21 | |
| 12 | 2012 | 28 | |
| 13 | 2008 | 39 | |
| 14 | Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapybreakdown → | 2005 | 1414 |
| 15 | 2005 | 41 | |
| 16 | 2005 | 34 | |
| 17 | 2004 | 8 | |
| 18 | 2003 | 140 | |
| 19 | 2003 | 46 | |
| 20 | Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. | 2003 | 168 |
About Mark Ayers
Mark Ayers is a scholar working on Cancer Research, Oncology, Otorhinolaryngology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 56 papers that have together received 7.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Cancer Genomics and Diagnostics (18 papers), Colorectal Cancer Treatments and Studies (10 papers), Lung Cancer Treatments and Mutations (9 papers), Gene expression and cancer classification (9 papers), Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (2.7k citations), Immunology (1.6k citations), Pulmonary and Respiratory Medicine (1.9k citations) and Pathology and Forensic Medicine (780 citations). Mark Ayers has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Lajos Pusztai, James Stec, Jared Lunceford, W. Fraser Symmans, Jeffrey S. Ross, Gabriel N. Hortobágyi, Andrey Loboda, Sarina A. Piha‐Paul, Andrew Albright and Michael Nebozhyn. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Cancer Research and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.